Literature DB >> 19009974

The biology of nerve injury in leprosy.

David M Scollard1.   

Abstract

The steps in the pathogenesis of nerve injury in leprosy are depicted in Figure 1. Localisation of M. leprae to nerve, Schwann cell infection & responses, as yet unknown mechanisms of injury, axonal atrophy, and finally demyelination. These steps, and the mechanisms responsible for them, occur quickly in the course of this disease (as noted, even the earliest diagnostic lesions have sensory abnormalities), but they are also chronic processes that may contribute to progressive nerve injury over a period of many years unless interrupted by treatment, and even after cure of the infection in some patients. A common feature throughout this pathogenesis is inflammation--within and around the nerve. Inflammation is not only defined by its chemical mediators such as cytokines and chemokines, but by one of the most basic phenomena of inflammation--edema. The extent to which edema might contribute to nerve injury in leprosy has not been reviewed because it has not been studied in nerves affected by leprosy, although clinically, surgeons who perform neurolysis are convinced that they are decompressing nerves sustaining injury due to increased (edematous?) pressure. Inflammation in and around nerves is undoubtedly driven, in part, by the immunological responses in each of the portions of the immunologic spectrum of leprosy, but some inflammatory phenomena may be non-specific inflammation related to infection and foreign material (i.e., mycobacterial components). Few if any fixed associations can be made between the steps outlined in this conceptual framework of events; even the depicted sequence of these events is uncertain. Considerable additional data is needed to determine the connections between these processes and their underlying mechanisms. Additionally, although much emphasis is given to myelinated fibres (and demyelination) in studies of the biology of leprosy neuropathy, the small, sensory fibres in the skin are not myelinated. Additional studies of mechanisms of injury to these nerves is required. The results of all of these studies can be reasonably expected to identify new points for clinical intervention in--and possibly the prevention of--nerve injury in leprosy.

Entities:  

Mesh:

Year:  2008        PMID: 19009974

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  34 in total

1.  Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy.

Authors:  L H Sampaio; A L M Sousa; M C Barcelos; S G Reed; M M A Stefani; M S Duthie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-12       Impact factor: 3.267

Review 2.  Leprosy in the 21st century.

Authors:  Cassandra White; Carlos Franco-Paredes
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 3.  The armadillo as a model for peripheral neuropathy in leprosy.

Authors:  Richard W Truman; Gigi J Ebenezer; Maria T Pena; Rahul Sharma; Gayathriy Balamayooran; Thomas H Gillingwater; David M Scollard; Justin C McArthur; Anura Rambukkana
Journal:  ILAR J       Date:  2014

Review 4.  Cutaneous Mycobacterial Infections.

Authors:  Carlos Franco-Paredes; Luis A Marcos; Andrés F Henao-Martínez; Alfonso J Rodríguez-Morales; Wilmer E Villamil-Gómez; Eduardo Gotuzzo; Alexandro Bonifaz
Journal:  Clin Microbiol Rev       Date:  2018-11-14       Impact factor: 26.132

Review 5.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

6.  Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.

Authors:  Sundeep Chaitanya; Mallika Lavania; Ravindra P Turankar; Samuel Raj Karri; U Sengupta
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

7.  Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection.

Authors:  Malcolm S Duthie; Maria T Pena; Amit P Khandhar; Alessandro Picone; Zachary MacMIllen; Richard W Truman; Linda B Adams; Steven G Reed
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-10       Impact factor: 4.813

8.  Biologics in Leprosy: A Systematic Review and Case Report.

Authors:  Anna L Cogen; Eglantine Lebas; Barbara De Barros; James P Harnisch; William R Faber; Diana N Lockwood; Stephen L Walker
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

9.  Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration.

Authors:  Zhiguo Chen; Sanjay Pradhan; Chiachi Liu; Lu Q Le
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

10.  Two patients with leprosy and the sudden appearance of inflammation in the skin and new sensory loss.

Authors:  Carlos Franco-Paredes; Jesse T Jacob; Barbara Stryjewska; Leo Yoder
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.